Open access · CC-BY
via OpenAlex
Impact of senescence‐associated secretory phenotype and its potential as a therapeutic target for senescence‐associated diseases
Sugiko Watanabe, Shimpei Kawamoto, Naoko Ohtani, Eiji Hara
Cancer Science · 2017 · ▲ 312 citations
Abstract
"Cellular senescence(definition)" is a state in which cells undergo irreversible cell cycle arrest in response to a variety of cellular stresses. Once cells senesce, they are strongly resistant to any mitogens, including oncogenic stimuli. Therefore, cellular senescence has been assumed to be a potent anticancer mechanism. Although irreversible cell-cycle arrest is traditionally considered the major characteristic of senescent cells, recent studies have revealed some additional functions. Most noteworthy is the increased secretion of various secretory proteins, such as inflammatory cytokines, chemokines, growth factors, and MMPs, into the surrounding extracellular fluid. These newly recognized senescent phenotypes, termed senescence-associated secretory phenotypes (SASPs), reportedly contribute to tumor suppression, wound healing, embryonic development, and even tumorigenesis promotion. Thus, SASPs appear to be beneficial or deleterious, depending on the biological context. As senescent cells are known to accumulate during the aging process in vivo, it is quite possible that their accumulation in aged tissues promotes age-associated functional decline and various diseases, including cancers, at least to some extent. Here, we focus on and discuss the functional and regulatory network of SASPs toward opening up new possibilities for controlling aging and aging-associated diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/cas.13184
- Canonical
- link ↗
- Fetched
- 2026-06-01 MST
Cite this
APA
Watanabe, S., Kawamoto, S., Ohtani, N., & Hara, E. (2017). Impact of senescence‐associated secretory phenotype and its potential as a therapeutic target for senescence‐associated diseases. <em>Cancer Science</em>. https://doi.org/10.1111/cas.13184
Vancouver
Watanabe S, Kawamoto S, Ohtani N, Hara E. Impact of senescence‐associated secretory phenotype and its potential as a therapeutic target for senescence‐associated diseases. Cancer Science. 2017. doi:10.1111/cas.13184.
BibTeX
@article{sugiko2017Impact,
title = {Impact of senescence‐associated secretory phenotype and its potential as a therapeutic target for senescence‐associated diseases},
author = {Sugiko Watanabe and Shimpei Kawamoto and Naoko Ohtani and Eiji Hara},
journal = {Cancer Science},
year = {2017},
doi = {10.1111/cas.13184},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2019
Open access · CC-BY
TGF-β Signaling in Cellular Senescence and Aging-Related Pathology
Nutrients 2018
Open access · CC-BY
Protective Role of Polyphenols against Vascular Inflammation, Aging and Cardiovascular Disease
EBioMedicine 2017
Open access · OA
Cellular Senescence: A Translational Perspective
Current Opinion in Clinical Nutrition & Metabolic Care 2014
Citation only
Cellular senescence and the senescent secretory phenotype in age-related chronic diseases
Diabetes 2015
Open access · OA
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Frontiers in Physiology 2023
Open access · CC-BY